Antiangiogenic potential of beta-blockers in the context of juvenile hemangioma treatment
Juvenile hemangiomas (JH) — the most common tumor of childhood, which is estimated by various investigators found in 3–10 % of newborns resulting from the local development of significant violations of neoangiogenesis regulation. Research objective: determination of comparative antiangiogenic effect...
Main Authors: | Vl. V. Dubensky, V. V. Dubensky |
---|---|
Format: | Article |
Language: | English |
Published: |
State Scientific Center of Dermatovenereology and Cosmetology
2019-07-01
|
Series: | Vestnik Dermatologii i Venerologii |
Subjects: | |
Online Access: | https://www.vestnikdv.ru/jour/article/view/481 |
Similar Items
-
Safe and Effective Treatment of Intracranial Infantile Hemangiomas with Beta-Blockers
by: Aoife Naughton, et al.
Published: (2021-07-01) -
Modern approaches to surgical treatment of juvenile hemangiomas
by: Dubensky V.V.
Published: (2015-09-01) -
Comparison of the Effectiveness of Topical and Oral Beta Blockers in the Treatment of Childhood Hemangiomas
by: Kerim Faruk YÜKSEL, et al.
Published: (2023-12-01) -
Infantile hemangioma in a V2 distribution: Treatment with nadolol
by: Mariah Giberson, et al.
Published: (2015-01-01) -
Infantile Hemangioma Treated with Oral Propranolol: Case Presentation
by: Raufi N, et al.
Published: (2021-08-01)